5.11
price down icon0.58%   -0.03
after-market アフターアワーズ: 5.11
loading
前日終値:
$5.14
開ける:
$5.09
24時間の取引高:
175.78K
Relative Volume:
0.43
時価総額:
$109.01M
収益:
$73.62M
当期純損益:
$-138.24M
株価収益率:
-0.779
EPS:
-6.56
ネットキャッシュフロー:
$-99.19M
1週間 パフォーマンス:
-7.59%
1か月 パフォーマンス:
-11.13%
6か月 パフォーマンス:
-65.38%
1年 パフォーマンス:
-57.94%
1日の値動き範囲:
Value
$5.035
$5.3067
1週間の範囲:
Value
$4.94
$5.7597
52週間の値動き範囲:
Value
$4.71
$17.80

Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile

Name
名前
Enanta Pharmaceuticals Inc
Name
セクター
Healthcare (1173)
Name
電話
617 607 0800
Name
住所
500 ARSENAL STREET, WATERTOWN, MA
Name
職員
131
Name
Twitter
@EnantaPharma
Name
次回の収益日
2024-11-25
Name
最新のSEC提出書
Name
ENTA's Discussions on Twitter

ENTA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ENTA
Enanta Pharmaceuticals Inc
5.11 109.01M 73.62M -138.24M -99.19M -6.56
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
461.68 118.90B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
672.98 73.95B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
655.13 39.81B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
271.31 34.99B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
123.77 29.67B 3.30B -501.07M 1.03B -2.1146

Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-08-09 ダウングレード JP Morgan Neutral → Underweight
2023-08-08 ダウングレード Jefferies Buy → Hold
2022-12-09 開始されました H.C. Wainwright Buy
2022-07-06 アップグレード Evercore ISI In-line → Outperform
2022-06-01 アップグレード Evercore ISI Underperform → In-line
2021-10-07 開始されました Jefferies Buy
2021-09-09 開始されました SVB Leerink Mkt Perform
2021-01-29 アップグレード JP Morgan Underweight → Neutral
2020-11-24 開始されました Evercore ISI Underperform
2020-08-28 再開されました ROTH Capital Buy
2020-08-26 開始されました Piper Sandler Overweight
2020-07-27 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2020-03-17 アップグレード Robert W. Baird Neutral → Outperform
2019-11-22 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2019-09-26 ダウングレード JP Morgan Neutral → Underweight
2019-05-24 開始されました Wolfe Research Outperform
2019-04-23 アップグレード Berenberg Hold → Buy
2018-12-13 開始されました Berenberg Hold
2018-06-06 開始されました ROTH Capital Buy
2018-02-08 ダウングレード JP Morgan Overweight → Neutral
2018-01-02 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2017-11-21 繰り返されました RBC Capital Mkts Outperform
2017-09-15 開始されました RBC Capital Mkts Outperform
2017-07-11 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2016-04-28 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2016-02-09 繰り返されました Barclays Underweight
2015-10-23 ダウングレード Barclays Equal Weight → Underweight
2015-10-23 アップグレード JMP Securities Mkt Perform → Mkt Outperform
すべてを表示

Enanta Pharmaceuticals Inc (ENTA) 最新ニュース

pulisher
Feb 01, 2025

Enanta Pharmaceuticals (ENTA) Projected to Post Earnings on Wednesday - MarketBeat

Feb 01, 2025
pulisher
Jan 30, 2025

Petri Dish: A monthly Alzheimer's drug from Biogen; Watertown biotech CEO pay falls 66% - The Business Journals

Jan 30, 2025
pulisher
Jan 29, 2025

Enanta Pharmaceuticals (ENTA) Expected to Announce Quarterly Earnings on Wednesday - Defense World

Jan 29, 2025
pulisher
Jan 25, 2025

Assenagon Asset Management S.A. Raises Stock Holdings in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Jan 25, 2025
pulisher
Jan 25, 2025

Assenagon Asset Management S.A. Buys 49,050 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - MarketBeat

Jan 25, 2025
pulisher
Jan 23, 2025

Recursion Pharmaceuticals (RXRX) Moves 8.9% Higher: Will This Strength Last? - Yahoo Finance

Jan 23, 2025
pulisher
Jan 21, 2025

JPMorgan Chase & Co. Increases Stock Position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Jan 21, 2025
pulisher
Jan 21, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Shares Purchased by JPMorgan Chase & Co. - MarketBeat

Jan 21, 2025
pulisher
Jan 21, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Shares Bought by Barclays PLC - Defense World

Jan 21, 2025
pulisher
Jan 20, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Jan 20, 2025
pulisher
Jan 20, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives $17.25 Average Target Price from Brokerages - MarketBeat

Jan 20, 2025
pulisher
Jan 16, 2025

Enanta stock hits 52-week low at $4.83 amid market challenges - Investing.com Australia

Jan 16, 2025
pulisher
Jan 15, 2025

Enanta stock hits 52-week low at $4.83 amid market challenges By Investing.com - Investing.com South Africa

Jan 15, 2025
pulisher
Jan 12, 2025

Jane Street Group LLC Has $240,000 Stake in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Jan 12, 2025
pulisher
Jan 11, 2025

ENTA (Enanta Pharmaceuticals) Peter Lynch Fair Value : N/A (As of Jan. 11, 2025) - GuruFocus.com

Jan 11, 2025
pulisher
Jan 09, 2025

Enanta stock hits 52-week low at $5.29 amid market challenges - Investing.com Nigeria

Jan 09, 2025
pulisher
Jan 08, 2025

Enanta Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire

Jan 08, 2025
pulisher
Jan 06, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Shares Purchased by Barclays PLC - Defense World

Jan 06, 2025
pulisher
Jan 05, 2025

Geode Capital Management LLC Has $4.95 Million Stake in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Jan 05, 2025
pulisher
Jan 04, 2025

(ENTA) Technical Pivots with Risk Controls - Stock Traders Daily

Jan 04, 2025
pulisher
Jan 01, 2025

Enanta stock touches 52-week low at $5.68 amid market challenges - Investing.com Australia

Jan 01, 2025
pulisher
Dec 31, 2024

Enanta stock touches 52-week low at $5.68 amid market challenges By Investing.com - Investing.com South Africa

Dec 31, 2024
pulisher
Dec 28, 2024

Brokers Issue Forecasts for ENTA Q1 Earnings - Defense World

Dec 28, 2024
pulisher
Dec 27, 2024

Equities Analysts Offer Predictions for ENTA Q1 Earnings - MarketBeat

Dec 27, 2024
pulisher
Dec 27, 2024

Paxlovid Survives Patent Dispute, Securing Pfizer’s Exclusive Rights - The Africa Logistics

Dec 27, 2024
pulisher
Dec 26, 2024

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

Dec 26, 2024
pulisher
Dec 26, 2024

FY2029 Earnings Estimate for ENTA Issued By HC Wainwright - Defense World

Dec 26, 2024
pulisher
Dec 26, 2024

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives $17.25 Average PT from Brokerages - MarketBeat

Dec 26, 2024
pulisher
Dec 25, 2024

Enanta Pharmaceuticals (NASDAQ:ENTA) Price Target Cut to $18.00 by Analysts at HC Wainwright - Defense World

Dec 25, 2024
pulisher
Dec 25, 2024

Equities Analysts Set Expectations for ENTA FY2029 Earnings - MarketBeat

Dec 25, 2024
pulisher
Dec 25, 2024

Pfizer prevails in Enanta patent case over Covid-19 drug By Investing.com - Investing.com Nigeria

Dec 25, 2024
pulisher
Dec 24, 2024

Enanta Pharmaceuticals stock remains Buy-rated with Phase 2 data driving model revisions - Investing.com Australia

Dec 24, 2024
pulisher
Dec 24, 2024

When (ENTA) Moves Investors should Listen - Stock Traders Daily

Dec 24, 2024
pulisher
Dec 24, 2024

Pfizer prevails in Enanta patent case over Covid-19 drug - Investing.com India

Dec 24, 2024
pulisher
Dec 24, 2024

Pfizer Gets Enanta Patent Voided in Case Over Paxlovid Royalties - Bloomberg Law

Dec 24, 2024
pulisher
Dec 24, 2024

Enanta Pharmaceuticals (ENTA) Appeals Court Ruling in Patent Dis - GuruFocus.com

Dec 24, 2024
pulisher
Dec 24, 2024

HC Wainwright Cuts Enanta Pharmaceuticals (NASDAQ:ENTA) Price Target to $18.00 - MarketBeat

Dec 24, 2024
pulisher
Dec 24, 2024

Enanta to appeal as Pfizer wins Paxlovid patent ruling - MSN

Dec 24, 2024
pulisher
Dec 24, 2024

Enanta stock slips as Pfizer wins Paxlovid patent (PFE:NYSE) - Seeking Alpha

Dec 24, 2024
pulisher
Dec 24, 2024

Enanta Pharmaceuticals to Appeal Ruling in Patent Infringement Case Against Pfizer - MarketWatch

Dec 24, 2024
pulisher
Dec 24, 2024

Enanta Pharma Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) - Benzinga

Dec 24, 2024
pulisher
Dec 24, 2024

Enanta Loses Key Patent Battle Against Pfizer Over COVID Drug Paxlovid in Court Ruling - StockTitan

Dec 24, 2024
pulisher
Dec 23, 2024

Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last? - Yahoo Finance

Dec 23, 2024
pulisher
Dec 19, 2024

Fmr LLC Purchases 7,839 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Dec 19, 2024

Enanta Pharmaceuticals Inc (ENTA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
大文字化:     |  ボリューム (24 時間):